Efficacy and tolerability of Laxatan Granulat in patients with chronic constipation
- PMID: 21694832
- PMCID: PMC3108648
- DOI: 10.2147/ceg.s6236
Efficacy and tolerability of Laxatan Granulat in patients with chronic constipation
Abstract
Background: On average 12% of the population worldwide suffer from acute or chronic constipation. Pathological intestine alterations, an unhealthy diet with reduced liquid intake, and little exercise are potential reasons. Often the motility of the intestine is disturbed. Changing nutrition habits or lifestyle is not always successful. In such cases, laxatives containing macrogol and inulin are highly effective.
Methodology: The efficacy and tolerability of Laxatan(®) Granulat, a laxative containing macrogol, inulin, and mineral salts, was assessed in a drug-monitoring study of 105 patients for four weeks.
Results: At the end of this study, a highly significant reduction of the constipation symptoms in 98.1% of the patients was observed. No adverse events were reported during this drug-monitoring study. The overall efficacy was rated as being "very good" or "good" for 96% and the overall tolerability was rated as being "very good" or "good" for 99% of patients.
Conclusion: The combination of macrogol, inulin, and mineral salts is highly effective in the treatment of chronic constipation. Due to its prebiotic activity, inulin probably leads to proliferation of lactic acid-producing bacteria. The lowered pH and increased water content probably increases the peristaltic action and therefore reduces constipation.
Keywords: Laxatan®; constipation; inulin; macrogol.
Figures
Similar articles
-
Constipation--modern laxative therapy.Support Care Cancer. 2003 Nov;11(11):679-85. doi: 10.1007/s00520-003-0525-x. Epub 2003 Sep 20. Support Care Cancer. 2003. PMID: 14505158 Review.
-
Pharmacoeconomic Impact of Low-Dose Macrogol 3350 plus Electrolytes Compared with Lactulose in the Management of Chronic Idiopathic Constipation among Ambulant Patients in Belgium.Clin Drug Investig. 2004;24(12):719-29. doi: 10.2165/00044011-200424120-00003. Clin Drug Investig. 2004. PMID: 17523735
-
Macrogol (polyethylene glycol) 4000 without electrolytes in the symptomatic treatment of chronic constipation: a profile of its use.Drugs Ther Perspect. 2018;34(7):300-310. doi: 10.1007/s40267-018-0532-0. Epub 2018 Jun 15. Drugs Ther Perspect. 2018. PMID: 30546252 Free PMC article.
-
Macrogol 3350 plus electrolytes for chronic constipation in children: a single-centre, open-label study.J Paediatr Child Health. 2007 Jul-Aug;43(7-8):527-31. doi: 10.1111/j.1440-1754.2007.01116.x. J Paediatr Child Health. 2007. PMID: 17635680
-
Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).Evid Based Child Health. 2013 Jan;8(1):57-109. doi: 10.1002/ebch.1893. Evid Based Child Health. 2013. PMID: 23878124 Review.
Cited by
-
Communication between the gut microbiota and peripheral nervous system in health and chronic disease.Gut Microbes. 2022 Jan-Dec;14(1):2068365. doi: 10.1080/19490976.2022.2068365. Gut Microbes. 2022. PMID: 35482894 Free PMC article. Review.
-
Effect of inulin in the treatment of irritable bowel syndrome with constipation (Review).Exp Ther Med. 2020 Dec;20(6):185. doi: 10.3892/etm.2020.9315. Epub 2020 Oct 13. Exp Ther Med. 2020. PMID: 33101475 Free PMC article. Review.
References
-
- Foxx-Orenstein AE, McNally MA, Odunsi ST. Update on constipation: one treatment does not fit all. Cleve Clin J Med. 2008;75:813–824. - PubMed
-
- Muller-Lissner SA, Kamm MA, Scarpignato C, Wald A. Myths and misconceptions about chronic constipation. Am J Gastroenterol. 2005;100:232–242. - PubMed
-
- DiPiro JT, Michael KA, Clark BA, et al. Absorption of polyethylene glycol after administration of a PEG-electrolyte lavage solution. Clin Pharm. 1986;5:153–155. - PubMed
-
- Schiller LR, Emmett M, Santa Ana CA, Fordtran JS. Osmotic effects of polyethylene glycol. Gastroenterology. 1988;94:933–941. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources